Imaging and image-guided procedures play an imperative role in the screening, diagnosis,
and surveillance of cancer. Although emerging imaging techniques now enable more …

Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …

Abstract Introduction The Blood First Assay Screening Trial is an ongoing open-label,
multicohort study, prospectively evaluating the relationship between blood-based next …

Screening for therapeutic targets is standard of care in the management of advanced non-
small cell lung cancer. However, most molecular assays utilize tumor tissue, which may not …

We reported unique molecular features of cerebrospinal fluid (CSF) of nonsmall cell lung
cancer (NSCLC) patients with leptomeningeal metastasis (LM), suggesting establishing CSF …

To augment the potential of precision therapy, improved diagnostic characterization of
tumors is pivotal. We suggest a comprehensive diagnostic framework combining tissue and …

Background Liquid biopsy (LB) is a laboratory test performed on a fluid sample aiming at
analyzing molecular data derived from circulating cells and related entities, or from nucleic …

OBJECTIVE: This study investigated the feasibility of using malignant pleural effusion (MPE)
supernatant and paired cell blocks (precipitate) for gene profiling in patients with non-small …

Abstract Background and Objectives The use of ultra-sensitive diagnostic tests to detect
clinically actionable somatic alterations within the gene encoding the epidermal growth …

Background: Lung cancer is one of the most common malignant tumors worldwide.
Currently, effective screening methods for early lung cancer are still scarce. Breath analysis …